Economic Impact of the Use of an Absorbable Adhesion Barrier in Preventing Adhesions Following Open Gynecologic Surgeries

Sanjoy Roy, Rashad Carlton, Carlton R, Weisberg M, Martin Weisberg, Ryan Clark, Clark R, Migliaccio-Walle K, Kristen Migliaccio-Walle, Chapa H, Hector Chapa
Journal of long-term effects of medical implants · 2015 · doi:10.1615/jlongtermeffmedimplants.2015012140 · PMID:26756563
other OA: closed public-domain-us
Full text JSON View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-07, 2026-07-16 ⓘ

An economic model estimates that using the GYNECARE INTERCEED absorbable adhesion barrier in 75% of open gynecologic surgeries could save US hospitals $540,823 over 3 years by reducing complications and readmissions.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-07, 2026-07-16 · read from full text ⓘ

The paper used an economic model to estimate the impact of using the GYNECARE INTERCEED absorbable adhesion barrier on postoperative adhesions across several open gynecologic procedures, including caesarean section, hysterectomy, myomectomy, ovarian, tubal, and endometriosis surgery, comparing scenarios with and without the barrier. Costs considered included incremental barrier material costs, complication-related medical costs, and adhesion-related readmissions, with barrier use assumed in 75% of procedures; the analysis used a United States hospital perspective over 3 years and assumed 100 surgeries of each type, averaging one sheet per surgery. Over the modeled 3-year period, the barrier produced a net estimated savings of $540,823, alongside 62 fewer patients developing adhesions, despite adding $137,250 in material costs that were offset by reductions in length of stay, readmissions, and operating room costs. This paper is centrally about endometriosis surgery among other open gynecologic operations; it explicitly includes endometriosis surgery in the economic model evaluating adhesion prevention with GYNECARE INTERCEED.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

We used an economic model to assess the impact of using the GYNECARE INTERCEED absorbable adhesion barrier for reducing the incidence of postoperative adhesions in open surgical gynecologic procedures. Caesarean section surgery, hysterectomy, myomectomy, ovarian surgery, tubal surgery, and endometriosis surgery were modeled with and without the use of GYNECARE INTERCEED absorbable adhesion barrier. Incremental GYNECARE INTERCEED absorbable adhesion barrier material costs, medical costs arising from complications, and adhesion-related readmissions were considered. GYNECARE INTERCEED absorbable adhesion barrier use was assumed in 75% of all procedures. The economic impact was reported during a 3-year period from a United States hospital perspective. Assuming 100 gynecologic surgeries of each type and an average of one GYNECARE INTERCEED absorbable adhesion barrier sheet per surgery, a net savings of $540,823 with GYNECARE INTERCEED absorbable adhesion barrier during 3 years is estimated. In addition, GYNECARE INTERCEED absorbable adhesion barrier use resulted in 62 fewer cases of patients developing adhesions. Although the use of GYNECARE INTERCEED absorbable adhesion barrier added $137,250 in material costs, this was completely offset by the reduction in length of stay ($178,766 savings), fewer adhesion-related readmissions ($458,220 savings), and operating room cost ($41,078 savings). Adoption of the GYNECARE INTERCEED absorbable adhesion barrier for appropriate gynecologic surgeries would likely result in significant savings for hospitals, driven primarily by clinical patient benefits in terms of decreased length of stay and adhesion-related readmissions.
Full text 2,584 characters · extracted from oa-doi-fallback · click to expand
Journal of Long-Term Effects of Medical Implants Published 4 issues per year ISSN Print: 1050-6934 ISSN Online: 1940-4379 Economic Impact of the Use of an Absorbable Adhesion Barrier in Preventing Adhesions Following Open Gynecologic Surgeries ABSTRACT We used an economic model to assess the impact of using the GYNECARE INTERCEED® absorbable adhesion barrier for reducing the incidence of postoperative adhesions in open surgical gynecologic procedures. Caesarean section surgery, hysterectomy, myomectomy, ovarian surgery, tubal surgery, and endometriosis surgery were modeled with and without the use of GYNECARE INTERCEED® absorbable adhesion barrier. Incremental GYNECARE INTERCEED absorbable adhesion barrier material costs, medical costs arising from complications, and adhesion-related readmissions were considered. GYNECARE INTERCEED absorbable adhesion barrier use was assumed in 75% of all procedures. The economic impact was reported during a 3-year period from a United States hospital perspective. Assuming 100 gynecologic surgeries of each type and an average of one GYNECARE INTERCEED absorbable adhesion barrier sheet per surgery, a net savings of $540,823 with GYNECARE INTERCEED absorbable adhesion barrier during 3 years is estimated. In addition, GYNECARE INTERCEED absorbable adhesion barrier use resulted in 62 fewer cases of patients developing adhesions. Although the use of GYNECARE INTERCEED absorbable adhesion barrier added $137,250 in material costs, this was completely offset by the reduction in length of stay ($178,766 savings), fewer adhesion-related readmissions ($458,220 savings), and operating room cost ($41,078 savings). Adoption of the GYNECARE INTERCEED absorbable adhesion barrier for appropriate gynecologic surgeries would likely result in significant savings for hospitals, driven primarily by clinical patient benefits in terms of decreased length of stay and adhesion-related readmissions. - Goldberg Jeffrey M., Falcone Tommaso, Diamond Michael P., Current controversies in tubal disease, endometriosis, and pelvic adhesion, Fertility and Sterility, 112, 3, 2019. Crossref - Osman Mustafa Abdallah Ahmed, Mohamed Hamdy A., Ibrahim Adel A., Surgicel for Prevention of Postoperative Adhesions in Laparoscopic Myomectomy: A Propensity Score-Matching Analysis, Journal of Gynecologic Surgery, 38, 2, 2022. Crossref - Imai Ken, Chikazawa Kenro, Misawa Masahiro, Kuwata Tomoyuki, A novel technique for applying interceed® in laparoscopic surgery: The triangle I-CEED method, Gynecology and Minimally Invasive Therapy, 11, 3, 2022. Crossref

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Absorbable Implants Cellulose, Oxidized Gynecologic Surgical Procedures Tissue Adhesions Tissue Adhesions Absorbable Implants Cellulose, Oxidized Cellulose, Oxidized Female Gynecologic Surgical Procedures Humans Length of Stay Length of Stay Models, Economic Operating Rooms Operating Rooms Patient Readmission Patient Readmission Tissue Adhesions Tissue Adhesions

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-08-11T06:11:44.160905+00:00
pubmed
last seen: 2026-05-13T22:21:19.813018+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine